mayo clinic glp 1 researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s.⁠ ⁠ The test estimates an individual's calories to satiation ( GLP-1 Agonists: A Comprehensive Overview

Ongoing clinical trials are investigating the anti-cancer potential of sulfasalazine in metastatic colorectal cancer (NCT06134388), breast cancer (NCT03847311), and acute myeloid leukemia (NCT05580861)

Thirteen studies included only males or females (46, 56, 59, 63, 64, 69, 72, 73, 78, 80), and 28 included both sexes (43, 45, 4855, 57, 58, 6062, 6568, 70, 71, 74, 76, 77, 79)

Thus GLP-1 was shown to regulate a number of diverse functions: reduction in digestive enzyme secretion, slowing of gastric motility, increases in heart rate and blood flow, increased bone remodeling, and suppression of appetite (via hypothalamic and brainstem nuclei)

[DOI] [PubMed] [Google Scholar] 305.Long J.B., Jay S.M., Segal S.S., Madri J.A